Abstract
It is not uncommon for cancer geneticists to be referred families with apparently Mendelian co-inheritance of breast and bowel cancer. Such families present a particular problem as regards the intensity of their screening for these diseases and the utility of genetic testing. Many 'breast-colon' cancer families probably result from chance clustering of two common cancers. Other 'breast-colon' cancer families may result from known cancer syndromes, such as hereditary breast-ovarian cancer or hereditary non-polyposis colon cancer, either by conferring a high risk of one cancer type and a slightly increased risk of the other, or through a predisposition to one of the two cancers and chance occurrence of the other. Anecdotally, however, many geneticists wonder about the existence of a distinct 'breast-colon cancer syndrome', since some families present good a priori evidence of genetic disease and yet cannot readily be accounted for by known genes or chance. The identification of unknown 'breast-colon cancer' genes is likely to be difficult, relying primarily on candidate gene analysis, including loci separately implicated in breast or colorectal cancer, or in other multiple cancer syndromes. Studies such as those on APC I1307K and CHEK2 1100delC may suggest the way forward for the identification of 'breast-colon cancer' genes.
This is a preview of subscription content, log in via an institution to check access.
References
Houlston RS, Peto J. Genetics and the common cancers. In Eeles RA et al. (eds), Genetic Predisposition to Cancer. Chapman Hall: London, 1996.
Aarnio M et al. Cancer risk in mutation carriers of DNA mismatch-repair genes. Int J Cancer 1999; 81(2): 214-8.
Risinger JI et al. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996; 77(9): 1836-43.
Ford D et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343(8899): 692-5.
Nelen MR et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997; 6(8): 1383-7.
Zhou XP et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 2001; 69(4): 704-11.
Eng C. Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 1998; 12(3): 701-10.
Tomlinson IP, Houlston RS. Peutz-Jeghers syndrome. J Med Genet 1997; 34(12): 1007-11.
Easton DF et al. The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium. Lancet 1994; 344(8924): 761.
Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91(15); 1310-6.
Lin KM et al. Colorectal cancer in hereditary breast cancer kindreds. Dis Colon Rectum, 1999; 42(8): 1041-5.
Risch HA et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001; 68(3): 700-10.
Evans HS et al. Cancer risks in women with 2 breast or ovarian cancers: clues to genetic cancer susceptibility. Int J Cancer 2001; 94(5): 758-9.
Chen-Shtoyerman R et al. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients. Br J Cancer 2001; 84(4): 475-7.
Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71(3): 677-85.
Boyd J et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999; 53(1): 87-91.
Peelen T et al. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis. Int J Cancer 2000; 88(5): 778-82.
Vasen HF, Morreau H, Nortier JW. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001; 68(6): 1533-5.
Scott RJ et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68(1): 118-27.
Houlston R, Tomlinson I. Detecting low penetrance genes in cancer: the way ahead. J Med Genet 2000; 37: 161-7.
Meijers-Heijboer H et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31(1): 55-9.
Laken SJ et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997; 17: 79-83.
Woodage T et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998; 20(1): 62-5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipton, L., Thomas, H.J.W., Eeles, R.A. et al. Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene?. Familial Cancer 1, 189–195 (2001). https://doi.org/10.1023/A:1021101014264
Issue Date:
DOI: https://doi.org/10.1023/A:1021101014264